Grace Colon, Founder of InCarda Therapeutics

Grace Colon is the founder of InCarda Therapeutics. InCarda Therapeutics has raised $120M in total funding. Latest round: Series C. Backed by Innoviva.

About Grace Colon

Grace E. Colón, Ph.D., is a biotechnology CEO and board member. She previously served as CEO of InCarda Therapeutics, where she raised over $120M and advanced their lead product for paroxysmal atrial fibrillation from preclinical to Phase 3. She is currently the co-founder and CEO of Inaya Therapeutics.

Grace Colon at a glance

More founders in Boston, MA (44)

Browse related founder lists (3)

Full founder directory · Investor directory · Company funding database · Fundraising library